The Smith Kline & French lecture 1987. Clinical pharmacology and the art of bespoke prescribing.
作者信息
Routledge P A
机构信息
Department of Pharmacology and Therapeutics, University of Wales College of Medicine, Heath Park, Cardiff.
出版信息
Br J Clin Pharmacol. 1988 Oct;26(4):339-45. doi: 10.1111/j.1365-2125.1988.tb03390.x.
Abstract
摘要
相似文献
1
The Smith Kline & French lecture 1987. Clinical pharmacology and the art of bespoke prescribing.
Br J Clin Pharmacol. 1988 Oct;26(4):339-45. doi: 10.1111/j.1365-2125.1988.tb03390.x.
2
Aggressive heparin therapy for DVT.
Kans Med. 1993 Mar;94(3):87-8.
3
Warfarin therapy: evolving strategies in anticoagulation.
Am Fam Physician. 1999 Feb 1;59(3):635-46.
4
Influence of the concomitant use of heparin on the effects of warfarin during catheter ablation for atrial fibrillation.
Heart Vessels. 2016 Mar;31(3):397-401. doi: 10.1007/s00380-014-0608-2. Epub 2014 Dec 4.
5
Left atrial massive thrombus formation on the transseptal sheath despite adequate anticoagulation with warfarin and heparin during pulmonary vein isolation.
J Cardiovasc Electrophysiol. 2013 Oct;24(10):1185. doi: 10.1111/jce.12182. Epub 2013 Jun 7.
6
[Advantages and disadvantages of warfarin and pradaxa therapy for venous thromboembolism].
Vestn Khir Im I I Grek. 2014;173(4):87-91.
7
Lidocaine therapy: time for re-evaluation.
Clin Pharm. 1993 Jul;12(7):527-8.
8
Chronically anticoagulated patients who need surgery: can low-molecular-weight heparins really be used to "bridge" patients instead of intravenous unfractionated heparin?
Catheter Cardiovasc Interv. 2009 Jul 1;74 Suppl 1:S17-21. doi: 10.1002/ccd.22000.
9
[Intravenous lidocaine: an increasing but unauthorized prescription].
Ann Fr Anesth Reanim. 2014 Sep-Oct;33(9-10):550-1. doi: 10.1016/j.annfar.2014.06.010. Epub 2014 Oct 2.
10
Post-operative heparin may not be required for transitioning patients with a HeartMate II left ventricular assist system to long-term warfarin therapy.
J Heart Lung Transplant. 2010 Jun;29(6):616-24. doi: 10.1016/j.healun.2010.02.003. Epub 2010 Apr 18.
引用本文的文献
1
The effects of food on drug bioavailability.
Br J Clin Pharmacol. 1989 Dec;28(6):621-8. doi: 10.1111/j.1365-2125.1989.tb03554.x.
2
Clinical pharmacokinetic considerations in the elderly. An update.
Clin Pharmacokinet. 1989 Oct;17(4):236-63. doi: 10.2165/00003088-198917040-00003.
3
Long-term anticoagulation. Indications and management.
West J Med. 1989 Oct;151(4):414-29.
本文引用的文献
1
The discovery of dicumarol and its sequels.
Circulation. 1959 Jan;19(1):97-107. doi: 10.1161/01.cir.19.1.97.
2
Lignocaine and indocyanine green kinetics in patients following myocardial infarction.
Br J Clin Pharmacol. 1980 Oct;10(4):353-61. doi: 10.1111/j.1365-2125.1980.tb01771.x.
3
Reduction in lidocaine clearance during continuous infusion and by coadministration of propranolol.
N Engl J Med. 1980 Aug 14;303(7):373-7. doi: 10.1056/NEJM198008143030705.
4
Relationship between alpha 1-acid glycoprotein and lidocaine disposition in myocardial infarction.
Clin Pharmacol Ther. 1981 Aug;30(2):154-7. doi: 10.1038/clpt.1981.141.
5
Increased alpha-1-acid glycoprotein and lidocaine disposition in myocardial infarction.
Ann Intern Med. 1980 Nov;93(5):701-4. doi: 10.7326/0003-4819-93-5-701.
6
Control of lidocaine therapy: new perspectives.
Ther Drug Monit. 1982;4(3):265-70. doi: 10.1097/00007691-198208000-00003.
7
Predicting the dose of warfarin for therapeutic anticoagulation.
Thromb Haemost. 1982 Jun 28;47(3):230-1.
8
Effect of hypotension on liver blood flow and lidocaine disposition.
N Engl J Med. 1982 Sep 30;307(14):866-9. doi: 10.1056/NEJM198209303071406.
9
Increased toxicity and reduced clearance of lidocaine by cimetidine.
Ann Intern Med. 1982 May;96(5):592-4. doi: 10.7326/0003-4819-96-5-592.
10
Influence of long-term infusions on lidocaine kinetics.
Clin Pharmacol Ther. 1982 Apr;31(4):433-7. doi: 10.1038/clpt.1982.56.
Zotero 插件